Latest filing published 31 Jan 2023 for Solid Biosciences Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Carl Ashley Morris: trading record in brief
This profile gathers the share dealings of Carl Ashley Morris in Solid Biosciences Inc., where the filings describe the role as senior executive. Between 25 July 2019 and 27 January 2023, the trades on record add up to 13 filings.
On the market, this insider has only sold: 7 sales, €223k in total. The rest of the record consists of 3 share grants and 3 option exercises. In 2023 alone, the filings show no purchases and 1 sale.
The record was last updated on 31 January 2023 with an open-market sale (€3,032) in Solid Biosciences Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Carl Ashley Morris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,233 sharesCommon StockSEC:0000899243-23-003085:0
- 11,269 shares@ US$1.10100.0% of flowCommon StockSEC:0001209191-22-018885:0
2 of 2 declarations
